Malta vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Malta
100.0%
in 2023
Sur
82.0%
in 2024
Malta rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Malta
- Sur
How they compare
Malta currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Malta's figure about 1.2 times Sur's.
Across all 6 years both countries report, Malta has been ahead every year.
Malta ranks 1st and Sur ranks 2nd of 144 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malta | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 32.0% | 68.0% | Malta |
| 2010s | 100.0% | 59.0% | 41.0% | Malta |
| 2020s | 100.0% | 81.3% | 18.7% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Malta or Sur?
- Malta, at 100.0% against 82.0% in Sur as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Malta and Sur?
- 18.0%, with Malta ahead.
- How many years of comparable data are there for Malta and Sur?
- 6 years are reported by both, from 2008 to 2023.
- How do Malta and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Malta ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.